Showing results (11-20 of 45) with videos related to

Sort By:
Pageof 5
World Journal of Gastroenterology|July 11, 2013
Severe irinotecan-induced toxicity in a patient with UGT1A1 28 and UGT1A1 6 polymorphismsJian-Ming Xu, Yan Wang, Fei-Jiao Ge, et al.
Cancer|October 23, 2019
Facilities that service economically advantaged neighborhoods perform surgical metastasectomy more often for patients with colorectal liver metastasesAbhineet Uppal, Fabrice Smieliauskas, Manish R Sharma, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 31, 2012
Resampling phase III data to assess phase II trial designs and endpointsManish R Sharma, Theodore G Karrison, Yuyan Jin, et al.
Journal of Clinical Pharmacology|July 6, 2019
Prolonged Pharmacokinetic Interaction Between Capecitabine and a CYP2C9 Substrate, CelecoxibJacqueline Ramírez, Larry K House, Theodore G Karrison, et al.
Journal of Experimental & Clinical Cancer Research : CR|December 11, 2014
KRAS mutations in tumor tissue and plasma by different assays predict survival of patients with metastatic colorectal cancerJian-Ming Xu, Xiao-Jing Liu, Fei-Jiao Ge, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 11, 2016
Genotype-Guided Dosing Study of FOLFIRI plus Bevacizumab in Patients with Metastatic Colorectal CancerGiuseppe Toffoli, Manish R Sharma, Elena Marangon, et al.
Plos One|March 10, 2018
Treatment outcomes and HPV characteristics for an institutional cohort of patients with anal cancer receiving concurrent chemotherapy and intensity-modulated radiation therapyCorey C Foster, Andrew Y Lee, Larissa V Furtado, et al.
Plos One|July 6, 2018
Correction: Treatment outcomes and HPV characteristics for an institutional cohort of patients with anal cancer receiving concurrent chemotherapy and intensity-modulated radiation therapyCorey C Foster, Andrew Y Lee, Larissa V Furtado, et al.
Investigational New Drugs|March 14, 2024
A phase 1 trial of the MEK inhibitor selumetinib in combination with pembrolizumab for advanced or metastatic solid tumorsMaxime Chénard-Poirier, Aaron R Hansen, Martin E Gutierrez, et al.
Surgery|October 10, 2018
Obstruction predicts worse long-term outcomes in stage III colon cancer: A secondary analysis of the N0147 trialFadi S Dahdaleh, Scott K Sherman, Elizabeth C Poli, et al.
Pageof 5